


The objective of this Fund is to achieve income and capital growth through investment primarily in a range of equity and equity-related securities.
| Name | % Net Assets |
|---|---|
| ConocoPhillips | 2.7% |
| British American Tobacco plc | 2.5% |
| Nestle | 2.5% |
| Centrica plc | 2.2% |
| AstraZeneca plc | 2.1% |
| Du Pont | 2.1% |
| Pepsico Inc | 2.1% |
| Vodafone Group plc | 2.1% |
| Philip Morris International | 2.1% |
| Allianz | 2.0% |
| Key | % Net Assets |
|---|---|
| 2.7% | |
| 2.5% | |
| 2.5% | |
| 2.2% | |
| 90.1% |
| Date | 10-May-2021 |
|---|---|
| NAV | 242.30p |
| Currency | GBP |
| Change | 0.000p |
| % | n/a |
| YTD change | 242.30p |
| YTD % | n/a |
| Fund Inception | 23/05/2008 |
|---|---|
| Fund Manager | n/a |
| TER | 1.77 (28-Feb-2013) |
| Minimum Investment | |
|---|---|
| Initial | n/a |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | n/a |
| Annual Mang't | 1.50% |
| Exit | n/a |
| Name | % |
|---|---|
| No risk data available. | |
You are here: research